Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Laboratorios SALVAT S.A. - Product Pipeline Review - 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 26 | Code: MRS - 18615


Global Markets Directs, Laboratorios SALVAT S.A. Product Pipeline Review 2014, provides an overview of the Laboratorios SALVAT S.A.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Laboratorios SALVAT S.A.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides brief overview of Laboratorios SALVAT S.A. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Laboratorios SALVAT S.A.s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Laboratorios SALVAT S.A.s pipeline products

Reasons to buy

Evaluate Laboratorios SALVAT S.A.s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Laboratorios SALVAT S.A. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Laboratorios SALVAT S.A.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Laboratorios SALVAT S.A. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Laboratorios SALVAT S.A.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Laboratorios SALVAT S.A. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table Of Content

Table of Contents 2
List of Tables 3
List of Figures 3
Laboratorios SALVAT S.A. Snapshot 4
Laboratorios SALVAT S.A. Overview 4
Key Information 4
Key Facts 4
Laboratorios SALVAT S.A.- Research and Development Overview 5
Key Therapeutic Areas 5
Laboratorios SALVAT S.A.- Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products- Monotherapy 8
Pipeline Products- Combination Treatment Modalities 9
Laboratorios SALVAT S.A.- Pipeline Products Glance 10
Laboratorios SALVAT S.A.- Late Stage Pipeline Products 10
Phase III Products/Combination Treatment Modalities 10
Laboratorios SALVAT S.A.- Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Laboratorios SALVAT S.A.- Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Laboratorios SALVAT S.A.- Drug Profiles 13
(fluocinolone acetonide + ciprofloxacin hydrochloride) 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
G-238 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
tarafenacin 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Stem Cell Therapy for Bone Regeneration 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Laboratorios SALVAT S.A.- Pipeline Analysis 18
Laboratorios SALVAT S.A.- Pipeline Products by Target 18
Laboratorios SALVAT S.A.- Pipeline Products by Route of Administration 19
Laboratorios SALVAT S.A.- Pipeline Products by Molecule Type 20
Laboratorios SALVAT S.A.- Pipeline Products by Mechanism of Action 21
Laboratorios SALVAT S.A.- Recent Pipeline Updates 22
Laboratorios SALVAT S.A.- Dormant Projects 23
Laboratorios SALVAT S.A.- Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24

Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 26
Disclaimer 26

List of Tables

Laboratorios SALVAT S.A., Key Information 4
Laboratorios SALVAT S.A., Key Facts 4
Laboratorios SALVAT S.A.- Pipeline by Indication, 2014 6
Laboratorios SALVAT S.A.- Pipeline by Stage of Development, 2014 7
Laboratorios SALVAT S.A.- Monotherapy Products in Pipeline, 2014 8
Laboratorios SALVAT S.A.- Combination Treatment Modalities in Pipeline, 2014 9
Laboratorios SALVAT S.A.- Phase III, 2014 10
Laboratorios SALVAT S.A.- Phase II, 2014 11
Laboratorios SALVAT S.A.- Preclinical, 2014 12
Laboratorios SALVAT S.A.- Pipeline by Target, 2014 18
Laboratorios SALVAT S.A.- Pipeline by Route of Administration, 2014 19
Laboratorios SALVAT S.A.- Pipeline by Molecule Type, 2014 20
Laboratorios SALVAT S.A.- Pipeline Products by Mechanism of Action, 2014 21
Laboratorios SALVAT S.A.- Recent Pipeline Updates, 2014 22
Laboratorios SALVAT S.A.- Dormant Developmental Projects,2014 23
Laboratorios SALVAT S.A., Subsidiaries 24

List of Figures

Laboratorios SALVAT S.A. - Pipeline by Top 10 Indication, 2014 6
Laboratorios SALVAT S.A. - Pipeline by Stage of Development, 2014 7
Laboratorios SALVAT S.A. - Monotherapy Products in Pipeline, 2014 8
Laboratorios SALVAT S.A. - Pipeline by Top 10 Target, 2014 18
Laboratorios SALVAT S.A. - Pipeline by Top 10 Route of Administration, 2014 19
Laboratorios SALVAT S.A. - Pipeline by Top 10 Molecule Type, 2014 20
Laboratorios SALVAT S.A. - Pipeline Products by Top 10 Mechanism of Action, 2014 21

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing